123 results
8-K
EX-99.2
ZOM
Zomedica Corp
8 Apr 20
Zomedica Pharmaceuticals Corp. Announces Public Offering
4:40pm
to satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as exclusive placement agent for the offering.
The warrants will have … offering, the risk that the public offering will not be consummated, the satisfaction of customary closing conditions related to the public offering
8-K
EX-99.2
ZOM
Zomedica Corp
6 Jul 20
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering
5:18pm
to close on or about July 7, 2020, subject to satisfaction of customary closing conditions.
Zomedica intends to use the net proceeds from the offering … expressed in the forward-looking information include, but are not limited to: market conditions, the completion of the public offering, the satisfaction
8-K
EX-99.1
ZOM
Zomedica Corp
9 Feb 21
Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares
5:22pm
and commissions. The closing of the offering is expected to occur on or about February 11, 2021, subject to satisfaction of customary closing conditions.
H.C … information include, but are not limited to: market and other conditions, the completion of the public offering, the satisfaction of customary closing
FWP
ZOM
Zomedica Corp
8 Feb 21
Free writing prospectus
5:09pm
, subject to satisfaction of customary closing conditions.
H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.
Zomedica also … of the public offering, the satisfaction of customary closing conditions related to the public offering and the intended use of net proceeds from
8-K
EX-99.1
ZOM
Zomedica Corp
4 Oct 21
Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan
6:15am
, enhance customer satisfaction for pet owners and increase profitability for their practices. My goal is for the TRUFORMA® point-of-care diagnostic … , sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial
FWP
z8z01sbpzvhqotnphe2p
9 Feb 21
Free writing prospectus
6:00am
8-K
EX-99.2
dlc3y
9 Feb 21
Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares
5:22pm
8-K
EX-99.1
h3ng8vlgi2
21 Jun 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-5.1
ob90it
27 Mar 19
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares
6:02am
8-K
EX-99.1
90w7w34my8qc 9iet
15 Aug 22
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million
6:12pm
S-8
EX-5.1
l6yev3poug01fj4m78kh
24 Jan 19
Registration of securities for employees
4:03pm
8-K
EX-99.1
wc3u056
13 Sep 23
Zomedica Provides Corporate Update
5:58pm
8-K
EX-99.1
j6heorsl f5dy
8 Jul 22
Zomedica Announces New Global Manufacturing & Distribution Center
6:03pm
8-K
EX-99.2
8kkioe0t
27 Mar 19
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares
6:02am
8-K
EX-99.1
m33 6gq7p5fc3yie
24 Aug 22
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
4:57pm
8-K
v2tsl3h
9 May 23
Other Events
8:57am
S-4
EX-5.1
1jn879e9i0 elv
9 Oct 20
Registration of securities issued in business combination transactions
1:57pm
8-K
EX-99.1
pfoa 3rmt5
6 Sep 23
Zomedica Closes Acquisition of Structured Monitoring Products adding revolutionary
8:18am